葡萄糖酶和葡萄糖酶激活剂
Changhong Li1, Yi Zhang2, Li Chen2
1Nanjing AscendRare and Hua Medicine, Nanjing, Jiangsu 210000, China.
Life metabolism
|January 28, 2025
概括
葡萄糖激酶 (GK) 功能障碍有助于2型糖尿病. 新的GK激活剂,如dorzagliatin,在修复胰腺和肝脏缺陷方面显示出希望,为T2D治疗提供希望.
科学领域:
- 生物化学 生化学
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
背景情况:
- 葡萄糖激酶 (GK) 对于葡萄糖平衡至关重要,在胰腺小岛和肝脏中充当葡萄糖传感器.
- 功能障碍的GK,无论是功能丧失 (高血糖症) 还是功能增加 (低血糖症),都会显著影响葡萄糖代谢.
- 在小岛和肝脏的mRNA和蛋白质水平上逐渐丧失GK被假设为2型糖尿病 (T2D) 发病的关键机制.
研究的目的:
- 探索葡萄糖酶 (GK) 在2型糖尿病 (T2D) 发病过程中的作用.
- 审查葡萄糖激酶激活剂 (GKA) 作为T2D治疗策略的发展.
- 突出新型GKAs的潜力,以多扎格里亚丁为例,解决T2D的潜在缺陷.
主要方法:
- 关于葡萄糖酶功能及其在糖尿病中的作用的现有文献的综述.
- 分析早期葡萄糖酶激活剂 (GKA) 发育失败背后的机制.
- 评估dorzagliatin在T2D治疗中的治疗潜力和成功.
主要成果:
- 葡萄糖酶 (GK) 功能障碍与高血糖和低血糖有关.
- 早期的葡萄激酶激活剂 (GKA) 开发受到其作用机制的不完全理解的阻碍.
- 多尔扎格利亚丁在T2D治疗中取得了成功,这表明了基于GK的治疗方法的可行模型.
结论:
- 葡萄糖激酶 (GK) 在葡萄糖调节中起着至关重要的作用,其逐渐丧失与2型糖尿病 (T2D) 有关.
- 有效的葡萄糖激酶激活剂 (GKA) 的开发为T2D提供了一个有前途的治疗途径.
- 多尔扎格利亚丁的成功证实了针对GK的策略,以修复T2D患者的胰腺和肝脏缺陷.
相关概念视频
Glucagon-like Receptor Agonists
294
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
294
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
Oral Hypoglycemic Agents: Glinides
136
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
136
Hormones Regulating Blood Glucose
3.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.0K
Protein Kinases and Phosphatases
13.0K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.0K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K


